Replay available

Prenetics Global Limited (PRE) Q2 2026 Earnings Call

Prenetics Global Limited (NASDAQ: PRE) Q2 2026 earnings conference call, held 2026-08-18. Replay captured from the company's public earnings webcast.

Tue, August 18, 2026 at 8:30 AMendedReplay
Prenetics Global Limited (PRE) Q2 2026 Earnings Call

Hosted by

Featured presenters

Caroline Levy

Board Member

Dr. Dawn Musalem

Chief Medical Officer & Founding Scientific Advisory Board Member

Ryan Myers

Research Analyst, Lake Street

Patrick Budistini

Research Analyst, UBS

Alex Hantman

Research Analyst, Sidoti

Tom Forte

Research Analyst, Maxim Group

George Kelly

Research Analyst, Roth MKM

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Prenetics Global Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.622 -- 00:00:03.264 Thank you, Shannon. Good morning, everyone. 00:00:03.264 -- 00:00:06.326 Before anything else, thank you so much for being here. 00:00:06.326 -- 00:00:08.607 This is actually the first 00:00:08.607 -- 00:00:12.550 live earnings video webcast we've done in our company's history. 00:00:12.550 -- 00:00:14.491 And from the numbers 00:00:14.491 -- 00:00:19.254 that are joining right now, it may be the largest group of our shareholders ever gathered 00:00:19.254 -- 00:00:24.597 in one place. So whether you manage a fund, hold a single share, or simply 00:00:24.597 -- 00:00:27.759 here because you drink the Shoshay every morning, welcome. 00:00:27.759 -- 00:00:30.041 This is for you. 00:00:30.041 -- 00:00:35.206 And here's why we're doing this way. Our shareholders range from global institutions 00:00:35.206 -- 00:00:39.730 to people who found IMA as customers and became shareholders. 00:00:39.730 -- 00:00:45.635 And we believe every one of them deserves the same depth of information at the same moment. 00:00:45.635 -- 00:00:49.699 This moment where we've opened the book to everyone at once. 00:00:49.699 -- 00:00:55.284 We can do that for a simple reason. We now have 20 months of data. 00:00:55.284 -- 00:01:00.188 Every cohort, every month, every market measured end to end. 00:01:00.188 -- 00:01:04.852 Enough history that numbers no longer need my adjectives. 00:01:04.852 -- 00:01:10.016 And I will say this plainly, I do not know of another company publicly traded or 00:01:10.016 -- 00:01:15.140 private that has shown its business in this level of detail in which we are showing you 00:01:15.140 -- 00:01:20.212 today. I just released a 40-page shareholder letter written to be read, 00:01:20.212 -- 00:01:25.416 not skimmed. An additional 80...